Cargando…

Spontaneous Spinal Epidural Hematoma from Rivaroxaban

Spontaneous spinal epidural hematoma (SSEH) is a rare diagnosis. One known risk factor is anti-coagulation medication. We present a case of SSEH in a 74-year-old male on rivaroxaban therapy who clinically presented with an intermittently resolving and then worsening neurological exam. Due to the ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldfine, Charlotte, Glazer, Catherine, Ratzan, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965116/
https://www.ncbi.nlm.nih.gov/pubmed/29849242
http://dx.doi.org/10.5811/cpcem.2018.2.37096
_version_ 1783325296887332864
author Goldfine, Charlotte
Glazer, Catherine
Ratzan, Richard M.
author_facet Goldfine, Charlotte
Glazer, Catherine
Ratzan, Richard M.
author_sort Goldfine, Charlotte
collection PubMed
description Spontaneous spinal epidural hematoma (SSEH) is a rare diagnosis. One known risk factor is anti-coagulation medication. We present a case of SSEH in a 74-year-old male on rivaroxaban therapy who clinically presented with an intermittently resolving and then worsening neurological exam. Due to the extremely high morbidity and mortality associated with this diagnosis, it is important to be aware of the various presentations and adverse effects related to novel anticoagulation.
format Online
Article
Text
id pubmed-5965116
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine
record_format MEDLINE/PubMed
spelling pubmed-59651162018-05-30 Spontaneous Spinal Epidural Hematoma from Rivaroxaban Goldfine, Charlotte Glazer, Catherine Ratzan, Richard M. Clin Pract Cases Emerg Med Case Report Spontaneous spinal epidural hematoma (SSEH) is a rare diagnosis. One known risk factor is anti-coagulation medication. We present a case of SSEH in a 74-year-old male on rivaroxaban therapy who clinically presented with an intermittently resolving and then worsening neurological exam. Due to the extremely high morbidity and mortality associated with this diagnosis, it is important to be aware of the various presentations and adverse effects related to novel anticoagulation. University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2018-04-05 /pmc/articles/PMC5965116/ /pubmed/29849242 http://dx.doi.org/10.5811/cpcem.2018.2.37096 Text en © 2018 Goldfine et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Case Report
Goldfine, Charlotte
Glazer, Catherine
Ratzan, Richard M.
Spontaneous Spinal Epidural Hematoma from Rivaroxaban
title Spontaneous Spinal Epidural Hematoma from Rivaroxaban
title_full Spontaneous Spinal Epidural Hematoma from Rivaroxaban
title_fullStr Spontaneous Spinal Epidural Hematoma from Rivaroxaban
title_full_unstemmed Spontaneous Spinal Epidural Hematoma from Rivaroxaban
title_short Spontaneous Spinal Epidural Hematoma from Rivaroxaban
title_sort spontaneous spinal epidural hematoma from rivaroxaban
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965116/
https://www.ncbi.nlm.nih.gov/pubmed/29849242
http://dx.doi.org/10.5811/cpcem.2018.2.37096
work_keys_str_mv AT goldfinecharlotte spontaneousspinalepiduralhematomafromrivaroxaban
AT glazercatherine spontaneousspinalepiduralhematomafromrivaroxaban
AT ratzanrichardm spontaneousspinalepiduralhematomafromrivaroxaban